Drug Stocks Ignoring Obamacare
The healthcare industry is thriving despite Obamacare's rocky rollout, says Terry Hisey, Vice Chairman Healthcare Life Sciences at Deloitte.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
